Menu

Tacrolimus-induced nephrotoxicity in proximal tubule cells sorted from iPSC-derived kidney organoids

Tacrolimus (TAC) is a first-line immunosuppressant used to prevent rejection after solid-organ transplantation, yet its clinical utility is limited by nephrotoxicity, which can progress to irreversible kidney injury or graft loss. The molecular mechanisms underlying TAC-induced nephrotoxicity remain insufficiently understood. Here, we systematically assessed TAC responses across human in vitro nephron model: proximal tubule cells sorted from iPSC-derived kidney organoids.

Details
Type
study
Internal ID
S-VHPS24
Release date
2026-03-18
Version
License
CC-BY
URL
https://www.ebi.ac.uk/biostudies/studies/S-VHPS24
DOI
10.6019/S-VHPS24
Publications

No linked publications available.

Files

No files listed.

Authors
Funding
  • [DRAFT] Dutch Research Agenda (NWA)
    [DRAFT] 1292.19.272
[DRAFT] Proximal tubule cells sorted from iPSC-derived kidney organoids
RRID: [DRAFT] CVCL_xxxx · Supplier: [DRAFT] specify iPSC line donor / source
Homo sapiens · Kidney · Proximal tubule · [DRAFT] iPSC-derived sorted proximal tubule cells
Structure for CID 445643
Tacrolimus
[draft] single / repeated / chronic — specify exposure
Duration: [DRAFT] specify [DRAFT] hours / days
Exposure concentration: [DRAFT] specify range [DRAFT] µM
Bioassays

Coming soon: normalization, model fitting, statistics, QC, etc.

Loading dataset citation…